You have 9 free searches left this month | for more free features.

ak117

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Trial (Cadonilimab, AK117, Oxaliplatin)

Not yet recruiting
  • Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
Jul 17, 2023

Tumors Malignant Trial in Shanghai (AK117)

Active, not recruiting
  • Neoplasms Malignant
  • AK117
  • Shanghai, Shanghai, China
    FuDan University Shanghai Cancer Center
Oct 8, 2022

Metastatic Triple-negative Breast Cancer, Locally Advanced Triple-negative Breast Cancer Trial in Changsha, Xiangyang (AK117,

Recruiting
  • Metastatic Triple-negative Breast Cancer
  • Locally Advanced Triple-negative Breast Cancer
  • AK117
  • +3 more
  • Changsha, China
  • +1 more
Sep 8, 2022

Metastatic Colorectal Cancer Trial in Guanzhou (AK112, AK117, Oxaliplatin)

Recruiting
  • Metastatic Colorectal Cancer
  • Guanzhou, Guangdong, China
    The Sixth Hospital,Sun Yat-sen University
Aug 1, 2022

Advanced Malignant Tumors Trial in Shanghai (AK104, AK117, Capecitabine tablets)

Recruiting
  • Advanced Malignant Tumors
  • Shanghai, China
    Shanghai Renji Hospital
Aug 9, 2022

Advanced Malignant Tumors Trial in Hangzhou (AK112, AK117, Carboplatin)

Recruiting
  • Advanced Malignant Tumors
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
May 10, 2022

Advanced Malignant Tumors Trial in Hangzhou (AK112, AK117, Chemotherapy)

Recruiting
  • Advanced Malignant Tumors
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jan 27, 2022

Myelodysplastic Syndrome Trial in Suzhou (AK117, Azacitidine)

Recruiting
  • Myelodysplastic Syndrome
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 21, 2021

Acute Myeloid Leukemia Trial in Hangzhou (AK117, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital´╝îZhejiang University School of Medi
Jul 21, 2021

Tumors Malignant Trial in Australia (AK117)

Not yet recruiting
  • Neoplasms Malignant
  • AK117
  • Sydney, New South Wales, Australia
  • +4 more
Apr 14, 2020